Propofol hemisuccinate suppression of experimental autoimmune encephalomyelitis

References

• Sagara Y, Hendler S, Khoh-Reiter S, Gillenwater G, Carlo D, Schubert D, Chang J. Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem 1999; 73: 2524
   PubMedGoogle Scholar
• Peters CE, Korcok J, Gelb AW, Wilson JX. Anesthetic concentrations of propofol protect against oxidative stress in primary astrocyte cultures: Comparison with hypothermia. Anesthesiology 2001; 94(2)313–321
   PubMedGoogle Scholar
• Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-Diisopropylphenol). Br J Anaesth 1992; 68: 613–618
   PubMed Web of Science ®Google Scholar
• Kvam C, Granese D, Flaibani A, Pollesello P, Paoletti S. Hyaluronan can be protected from free-radical depolymerisation by 2,6-diisopropylphenol, a novel radical scavenger. Biochem Biophys Res Commun 1993; 193: 927–933
   PubMedGoogle Scholar
• Musacchio E, Rizzoli V, Bianchi M, Bindoli A, Galzigna L. Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat. Pharmacol Toxicol 1991; 69: 75–77
   PubMedGoogle Scholar
• Bao YP, Williamson G, Tew D, Pllumb GW, Lambert N, Jones JG, Menon DK. Antioxidant effects of propofol in human hepatic microsomes: Concentration effects and clinical relevance. Br J Anaesth 1998; 81: 584–589
   PubMedGoogle Scholar
• Eriksson O, Pollesello P, Saris NE. Inhibition of lipid peroxidation in isolated rat liver mitochondria by the general anesthetic propofol. Biochem Pharmacol 1992; 44: 391–393
   PubMedGoogle Scholar
• Kokita N, Hara A. Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology 1996; 84: 117–127
   PubMed Web of Science ®Google Scholar
• Machlin LJ, Gabriel E. Kinetics of tissue alpha tocopherol uptake and depletion following administration of high levels of vitamin E. Ann NY Acad Sci 1982; 393: 48–59
   PubMed Web of Science ®Google Scholar
• Hall ED, Braughler JM, McCall JM. Antioxidant effects in brain and spinal cord injury. J Neurotrauma 1992; 9(Suppl. 1)S165–S172
   PubMedGoogle Scholar
• Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995; 32: 82–121
   Google Scholar
• Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaike T, Maeda H, Kiproski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997; 94: 2528–2533
   PubMed Web of Science ®Google Scholar
• Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski H. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1998; 95: 675
   PubMed Web of Science ®Google Scholar
• Koprowski H, Zheng YM, Heber-Katz E, Fraser N, Rorke L, Fu ZF, Hanlon C, Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 1993; 90: 3024
   PubMed Web of Science ®Google Scholar
• Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288(2)481–487
   PubMed Web of Science ®Google Scholar
• Milford CM, Lynch GS, Cross RS, LeVine SM. Testing lazaroids U-74389G and U-83836E for therapeutic value in experimental allergic encephalomyelitis in the Lewis rat. Res Commun Mol Pathol Pharmacol 1995; 87: 353
   PubMedGoogle Scholar
• Beckman JS. The doubled-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991; 15(1)53–59
   PubMedGoogle Scholar
• Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood- CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. Faseb J 2000; 14: 691
   PubMed Web of Science ®Google Scholar
• Orser BA, Miller DR. Propofol-benzodiazepine interactions: Insights from a “bench to bedside” approach. Can J Anaesth 2001; 48(5)439–445
   PubMedGoogle Scholar
• Brabb T, von Dassow P, Ordonez N, Schnabel B, Duke B, Goverman J. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J Exp Med 2000; 192(Number 6)871–880
   PubMedGoogle Scholar
• Masahiko T, Akira A, Maeda K, Ueda Y, Sato EF, Mitsuo S, Inoue M. Propofol versus midazolam regarding their antioxidant activities. Am J Crit Care Med 2003; 163: 26–31
   Google Scholar
• Kohjitani A, Miyawaki T, Funahashi M, Higuchi H, Matsuo R, Shimada M. Ketamine and midazolam differentially inhibit nonadrenergic noncholinergic lower esophageal sphincter relaxation in rabbits: Role of superoxide anion and ntric oxide synthase. Anesthesiology 2003; 98(2)449–458
   PubMed Web of Science ®Google Scholar
• Kim SN, Son SC, Lee SM, Kim CS, Yoo DG, Lee SK, Hur GM, Park JB, Jeon BH. Midazolam inhibits proinflammatory mediators in the lipopolysaccharide-activated macrophage. Anesthesiology 2006; 105(1)105–110
   PubMedGoogle Scholar
• Achiron A, Miron S, Lavie V, Margalit R, Biegon A. Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: Implications for the treatment of acute relapses of multiple sclerosis. J Neuroimmunol 2000; 102: 26–31
   PubMed Web of Science ®Google Scholar
• Milligan NM, Newcombe R, Compston DA. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry 1987; 50: 511–516
   PubMed Web of Science ®Google Scholar
• Frequin ST, Lamers KJ, Barkhof F, Born GF, Hommes OR. Follow-up study of MS patients treated with high-dose intr-venous methylprednisolone. Acta Neurol Scand 1994; 90: 105–110
   PubMedGoogle Scholar
• Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 2000; 14: 691–698
   PubMed Web of Science ®Google Scholar